New Diabetes Drug Glumetza Declared A Success

Filed in archive News on April 11, 2006

The latest drug to treat Type 2 diabetes has been declared successful.

Glumetza, the brand name for the oft-used drug Metformin--used by many patients as Glucophage-- does the same job as Glucophage, but only requires a once-daily dose.

Patients taking Glucophage, the currently marketed immediate release version of the drug (and generic forms of metformin) have been required to take it two or three times a day to ensure adequate dosing.

Depomed's Glumetzaâ„¢ (Metformin HCl extended-release tablets) offers patients the convenience of a once-daily medication.

By lengthening drug retention time in the stomach and controlling drug delivery, Depomed's AcuFormâ„¢ technology can significantly enhance the effectiveness of oral medications. Depending on the drug being administered, the benefits of using AcuFormâ„¢ technology can include increased bioavailability, less frequent dosing, lower costs and fewer side effects.

I haven't tried the drug, but I give a thumbs up to any potential reduction in injections or pills!

Will you try Glumetza?